Business Wire5d
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
Healio8d
Retina360: Advances in the Treatment of Geographic Atrophy and Retinal Vein Occlusion
They also will evaluate advances in imaging and current and emerging therapies for the treatment and management of retinal vein occlusion. Upon successful completion of this educational activity ...
Medscape15d
Diagnosis and Treatment of Subclavian Artery Occlusive Disease
[14] Vascular Access Access to the subclavian artery can be obtained ... more support for subtotal or total occlusions, as well as offering an easier path to cross these occlusions in a retrograde ...
Medscape18d
Surgical and Endovascular Treatment of Symptomatic Aberrant Right Subclavian Artery (Arteria Lusoria)
Kieffer and colleagues reported the largest single-center series with 33 patients treated for a symptomatic or aneurysmal lusorian artery. [8] The authors also reported a classification of ...